Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,460 | 216 | 68.8% |
| Travel and Lodging | $3,372 | 9 | 31.1% |
| Education | $10.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $5,440 | 32 | $0 (2019) |
| Medtronic, Inc. | $621.17 | 5 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $617.35 | 22 | $0 (2021) |
| Amgen Inc. | $541.81 | 35 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $370.16 | 18 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $360.78 | 14 | $0 (2023) |
| Abbott Laboratories | $333.09 | 3 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $302.79 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $267.56 | 4 | $0 (2021) |
| Esperion Therapeutics, Inc. | $231.78 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $213.06 | 9 | SCPHARMACEUTICALS INC. ($91.49) |
| 2023 | $443.63 | 17 | Amarin Pharma Inc. ($188.21) |
| 2022 | $694.06 | 19 | Medtronic, Inc. ($206.16) |
| 2021 | $1,384 | 24 | Medtronic, Inc. ($415.01) |
| 2020 | $319.71 | 12 | AstraZeneca Pharmaceuticals LP ($124.39) |
| 2019 | $1,052 | 43 | Medtronic Vascular, Inc. ($219.56) |
| 2018 | $3,292 | 50 | Medtronic Vascular, Inc. ($2,537) |
| 2017 | $3,443 | 52 | Medtronic Vascular, Inc. ($2,684) |
All Payment Transactions
226 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Obesity | ||||||
| 05/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/06/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 02/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/01/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $67.34 | General |
| Category: Cardiology | ||||||
| 01/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Cardiology | ||||||
| 12/18/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Cardiology | ||||||
| 11/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/02/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.98 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/15/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $41.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/05/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $76.33 | General |
| Category: Cardiovascular | ||||||
| 08/23/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: DIABETES | ||||||
| 07/24/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/29/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $3.75 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/22/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.38 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/17/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $111.88 | General |
| Category: Cardiovascular | ||||||
| 04/26/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.45 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/09/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: DIABETES | ||||||
| 02/23/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/21/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $15.45 | General |
| Category: Cardiology | ||||||
| 01/30/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.88 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/27/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 735 | 1,024 | $186,448 | $56,265 |
| 2022 | 10 | 621 | 1,044 | $220,211 | $70,102 |
| 2021 | 13 | 1,236 | 2,071 | $301,926 | $107,266 |
| 2020 | 14 | 1,190 | 2,088 | $327,594 | $82,272 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 297 | 473 | $116,006 | $39,123 | 33.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 35 | 35 | $23,842 | $4,630 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 44 | $7,612 | $2,662 | 35.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 210 | 268 | $11,474 | $2,578 | 22.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 14 | 16 | $7,599 | $2,075 | 27.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 15 | 26 | $4,872 | $1,463 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,828 | $1,264 | 33.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 33 | 53 | $6,197 | $1,170 | 18.9% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 33 | 53 | $3,373 | $821.61 | 24.4% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 16 | 16 | $983.50 | $289.76 | 29.5% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 16 | 16 | $481.00 | $138.24 | 28.7% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 12 | 12 | $180.00 | $48.92 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 339 | 691 | $152,078 | $57,360 | 37.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 33 | 35 | $31,990 | $4,913 | 15.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $6,310 | $1,963 | 31.1% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 17 | 22 | $3,388 | $1,235 | 36.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 105 | 124 | $5,456 | $1,203 | 22.0% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2022 | 23 | 23 | $8,418 | $1,116 | 13.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 27 | 49 | $7,105 | $928.07 | 13.1% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2022 | 28 | 50 | $3,250 | $700.10 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $1,961 | $620.45 | 31.6% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 16 | 17 | $255.00 | $63.26 | 24.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 379 | 747 | $150,894 | $71,717 | 47.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 231 | 274 | $37,538 | $11,790 | 31.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 352 | 693 | $30,492 | $6,556 | 21.5% |
About Dr. Ronald Sutor, MD
Dr. Ronald Sutor, MD is a Cardiovascular Disease healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407898422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Sutor, MD has received a total of $10,842 in payments from pharmaceutical and medical device companies, with $213.06 received in 2024. These payments were reported across 226 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,460).
As a Medicare-enrolled provider, Sutor has provided services to 3,782 Medicare beneficiaries, totaling 6,227 services with total Medicare billing of $315,904. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Oklahoma City, OK
- Active Since 06/12/2006
- Last Updated 01/22/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1407898422
Products in Payments
- XARELTO (Drug) $617.35
- Advisa (Device) $433.97
- Azure (Device) $392.85
- Micra (Device) $369.32
- LifeVest (Device) $360.78
- ELIQUIS (Drug) $316.32
- FARXIGA (Drug) $243.75
- Repatha (Biological) $240.07
- NEXLIZET (Drug) $231.78
- Vascepa (Drug) $228.41
- JARDIANCE (Drug) $221.72
- Absorb (Device) $215.82
- CareLink (Device) $196.61
- ENTRESTO (Drug) $164.61
- PRADAXA (Drug) $148.44
- Claria MRI (Device) $142.74
- Corlanor (Drug) $137.94
- VERQUVO (Drug) $135.73
- PRALUENT (Drug) $124.99
- HeartMate (Device) $117.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Oklahoma City
Warren Jackman, Md, MD
Cardiovascular Disease — Payments: $2.5M
George Chrysant, Md, MD
Cardiovascular Disease — Payments: $559,592
Dr. Riaz Sirajuddin, M.d, M.D
Cardiovascular Disease — Payments: $483,835
Sunny Po, Md, MD
Cardiovascular Disease — Payments: $285,383
Dr. John Summers, M.d, M.D
Cardiovascular Disease — Payments: $148,458
Dwight Reynolds, Md, MD
Cardiovascular Disease — Payments: $75,986